Stanford School of Medicine


BERG, in conjunction with the Stanford University School of Medicine, is involved in a Phase 1 clinical trial for its drug candidate BPM 31510 in glioblastoma multiforme.

BERG in the News!

BERG is making headlines.  Click here to see the latest breaking news, interviews, and press releases.